Jamie I Fletcher - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jamie I Fletcher

Showing results (41-50 of 60) with videos related to

Pageof 6

Sort By:

Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025

Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.

Biochemical Pharmacology|June 29, 2014

High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.

Cancer Research|May 20, 2016

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.

Science Advances|November 28, 2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.

European Journal of Cancer (Oxford, England : 1990)|July 24, 2017

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoJayne Murray, Emanuele Valli, Denise M T Yu, et al.

Journal of the National Cancer Institute|July 30, 2011

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.

Molecular Systems Biology|October 1, 2025

High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.

International Journal of Cancer|November 8, 2022

Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.

Cancer Research|September 11, 2019

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.

Science Advances|March 3, 2023

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.

Pageof 6

Search research articles

Showing results (41-50 of 60) with videos related to

Sort By:

Pageof 6

Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025

Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.

Biochemical Pharmacology|June 29, 2014

High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.

Cancer Research|May 20, 2016

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of DyskerinRosemary O'Brien, Sieu L Tran, Michelle F Maritz, et al.

Science Advances|November 28, 2025

Inclusion of JNK-independent drugs within multiagent chemotherapy improves response in relapsed high-risk neuroblastomaJeremy Z R Han, Monica Phimmachanh, Jordan F Hastings, et al.

European Journal of Cancer (Oxford, England : 1990)|July 24, 2017

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivoJayne Murray, Emanuele Valli, Denise M T Yu, et al.

Journal of the National Cancer Institute|July 30, 2011

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug effluxMichelle J Henderson, Michelle Haber, Antonio Porro, et al.

Molecular Systems Biology|October 1, 2025

High-throughput 3D engineered paediatric tumour models for precision medicineMoonSun Jung, Valentina Poltavets, Joanna N Skhinas, et al.

International Journal of Cancer|November 8, 2022

Inhibition of mitochondrial translocase SLC25A5 and histone deacetylation is an effective combination therapy in neuroblastomaJanith A Seneviratne, Daniel R Carter, Rituparna Mittra, et al.

Cancer Research|September 11, 2019

Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.

Science Advances|March 3, 2023

Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastomaJordan F Hastings, Sharissa L Latham, Alvin Kamili, et al.

Pageof 6